We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBE.WS
676
DELISTED
Switchback Energy Acquisition Corporation Warrants, exercisable for one share of Class A Common Stoc
SBE.WS
| $3.43M | 0.01% |
730,621
-69,379
| -9% | -$119K |
|
677
AGNC Investment
AGNC
$12.6B
| $3.42M | 0.01% |
245,614
-141,749
| -37% | -$1.95M |
|
678
IPG Photonics
IPGP
$3.69B
| $3.28M | 0.01% |
19,300
-1,300
| -6% | -$215K |
|
679
Vertiv
VRT
$106B
| $3.24M | 0.01% |
187,250
-1,812,373
| -91% | -$28.4M |
|
680
Franklin Resources
BEN
$17.3B
| $3.24M | 0.01% |
159,200
-9,800
| -6% | -$206K |
|
681
HF Sinclair
DINO
$14.7B
| $3.23M | 0.01% |
+163,800
| New | +$4.08M |
|
682
Dentsply Sirona
XRAY
$2.64B
| $3.2M | 0.01% |
73,100
+22,000
| +43% | +$973K |
|
|
SPAQ.WS
683
DELISTED
Spartan Energy Acquisition Corp. Warrants, each whole warrant exercisable for one Class A common sto
SPAQ.WS
| $3.19M | 0.01% |
728,682
-530,318
| -42% | -$2.03M |
|
|
CERE
684
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $3.13M | 0.01% |
+300,000
| New | +$3.17M |
|
685
Canadian Natural Resources
CNQ
$94.8B
| $3.12M | 0.01% |
398,190
-4,094,210
| -91% | -$36.9M |
|
686
Westlake Corp
WLK
$9.9B
| $3.12M | 0.01% |
49,295
-794,773
| -94% | -$46.9M |
|
687
Arq
ARQ
$90.6M
| $3.04M | 0.01% |
750,000
+450,000
| +150% | +$1.92M |
|
688
Oshkosh
OSK
$9.47B
| $2.99M | 0.01% |
40,674
-221,253
| -84% | -$17M |
|
689
PagerDuty
PD
$856M
| $2.98M | 0.01% |
+110,000
| New | +$3.09M |
|
690
Shift4
FOUR
$3.44B
| $2.94M | 0.01% |
60,747
-332,885
| -85% | -$14.8M |
|
|
CMRC
691
Commerce.com Inc Series 1
CMRC
$192M
| $2.92M | 0.01% |
+35,000
| New | +$3.06M |
|
692
Novavax
NVAX
$1.27B
| $2.71M | 0.01% |
25,000
-174,600
| -87% | -$21.3M |
|
693
Suncor Energy
SU
$71.8B
| $2.45M | 0.01% |
200,000
+50,000
| +33% | +$783K |
|
|
PAND
694
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| $2.29M | 0.01% |
+200,000
| New | +$3.42M |
|
|
DCT
695
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $2.27M | 0.01% |
+50,000
| New | +$2.02M |
|
|
IMTXW
696
DELISTED
Immatics N.V. Warrants
IMTXW
| $2.19M | 0.01% |
+625,000
| New | +$2.09M |
|
|
NINE
697
DELISTED
Nine Energy Service
NINE
| $2.19M | 0.01% |
1,936,470
+200,000
| +12% | +$319K |
|
698
EverQuote
EVER
$839M
| $2.15M | 0.01% |
55,772
| – | – |
|
699
Conduent
CNDT
$271M
| $2.06M | 0.01% |
648,411
-545,872
| -46% | -$1.62M |
|
|
EIGR
700
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.04M | 0.01% |
8,333
-8,334
| -50% | -$2.59M |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.